ReviewDiscover oncology2025

T-DM1 with concurrent radiotherapy in HER2-positive breast cancer: preclinical evaluation and mechanisms, prediction, and exploration of adverse effects.

Guangmin Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.